Streetbeat News

Analyst Ratings

BHC

RBC Capital analyst Douglas Miehm maintains a Sector Perform rating on Bausch Health Companies (NYSE:BHC) and raises the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 3:29 pm

ALTM

Mizuho analyst John Roberts has reiterated a Neutral rating on Arcadium Lithium (NYSE:ALTM) and lowered the price target from $6 to $5.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 3:24 pm

SSTK

Needham analyst Bernie McTernan reiterated a Buy rating on Shutterstock (NYSE:SSTK) and maintained a $60 price target.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 3:21 pm

ZBH

Canaccord Genuity analyst Caitlin Cronin reiterated a Hold rating on Zimmer Biomet Holdings (ZBH) and maintained a $130 price target.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 3:17 pm

DDOG

Canaccord Genuity analyst Kingsley Crane has reiterated a Buy rating on Datadog (NASDAQ:DDOG) and maintained a $150 price target.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 3:16 pm

C

Significant investor activity in Citigroup (NYSE:C) options shows a bullish stance, with 65% of trades being bullish. Notable trades include calls and puts with strike prices ranging from $35.0 to $65.0. Analysts have set an average target price of $74.33 for Citigroup, with recent upgrades from Morgan Stanley and Piper Sandler. Citigroup's current trading volume is 1,429,276, with a slight price increase to $55.95. The stock may be approaching overbought territory, with earnings expected in 49 days.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:15 pm

RUN

Financial analysts have observed a bullish trend in options trading for Sunrun (NASDAQ:RUN), with a significant portion of traders showing optimism. The analysis highlighted a preference for a price range between $12.5 and $20.0 for Sunrun. Recent options trading activity includes both calls and puts with varying sentiments and strike prices. Sunrun, a company specializing in residential solar energy systems, has seen its stock price decrease by -3.21% to $12.37. Analysts have set a consensus target price of $21.75 for Sunrun, with ratings ranging from Market Perform to Outperform.

Portfolio Pulse from Benzinga Insights

February 23, 2024 | 3:15 pm

BNTX

Canaccord Genuity analyst Bill Maughan reiterated a Buy rating on BioNTech (NASDAQ:BNTX) and maintained a $171 price target.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 3:13 pm

W

Canaccord Genuity analyst Maria Ripps reiterates a Buy rating on Wayfair (NYSE:W) and maintains an $80 price target.

Portfolio Pulse from Benzinga Newsdesk

February 23, 2024 | 3:10 pm